Friday, 31 October 2014

Symposium Sessions - Friday, 31 October 2014

The following Symposia sessions will take place on Friday 31 October 2014.

Please click here to download all symposia as one PDF.

Title of symposium

Section

Coordinator(s)

Room

Friday, 31 October 2014 - 08:00 - 10:00

19. The Union/CDC Late breaker session Tuberculosis Richard Hahner (USA),                   CN Paramasivan (India),                 Sarita Shah (USA) 112
20. Community-driven psychosocial support: don't forget medication counselling! TB/ Nurses and Allied Professionals Niranjan Konduri (USA),
Antonia Kwiecien (USA)
117
21. Practical considerations for successful contact tracing and linkage to care in low- and middle-income countries Tuberculosis E Jane Carter (USA),
Anna Mandalakas (USA)
111
22. Countries' experience in decentralising PMDT: community-based MDR-/XDR-TB care Tuberculosis Agnes Gebhard (Netherlands),
Alexander Golubkov (USA)
113
23. QMS implementation and accreditation of TB laboratories TB/Bacteriology and Immunology Stella van Beers (Netherlands), Heidemarie Albert (South Africa) 114
24. Mathematical approaches to better understand and tackle tuberculosis Tuberculosis Cris Vilaplana (Spain),
Pere-Joan Cardona (Spain)
115
25. Tobacco control, trade and international treaties Tobacco Pranay Lal (India) 116
26. Know your epidemic: fundamental to solutions for child TB Adult and Child Lung Health Stephen M Graham (Australia) 118/119
27. What practical steps are needed to achieve a patient-centered continuum of care in TB control? Civil Society Virginia Williams (Switzerland),
Sara Massaut (Netherlands)
120/121

Friday, 31 October 2014 - 14:30- 16:30

28. Adolescent TB, TB-HIV and MDR-TB: addressing a vulnerable population with unique needs using innovative Adult and Child Lung Health Lisa Nelson (Switzerland) 112
29. Management of latent tuberculosis infection: from evidence to policy Tuberculosis Alberto Matteelli (Italy),
Andreas Sandgren (Sweden)
117
30. TB in Europe: MDR-/XDR-TB control and challenges of high risk groups Tuberculosis Dominik Zenner (UK),
Andrei Dadu (Moldova)
111
31. Implementing "FAST": a re-focused approach to institutional TB transmission control Tuberculosis Edward Nardell (USA) 113
32. Changing the status quo in TB drug and regimen R&D Tuberculosis Grania Brigden (France) 114
33. TB patients: learning from the experience of those personally affected Civil Society Victoria Garland (USA),
Jenniffer Dietrich (Switzerland)
115
34. Supervision or support? A debate panel on challenges around DOT and patient-centered care TB/ Nurses and Allied Professionals Tiemi Arakawa (Brazil) 116
35. Biosafety for TB laboratories: involving local professional associations in practical sustainable approaches TB/Bacteriology and Immunology Maureen Ellis (Canada) 118/119
36. Tobacco, poverty and possible solutions: health promotion funding models Tobacco Kayleigh Bleymann (UK),
Jonathan Romo (Mexico)
120/121